160 related articles for article (PubMed ID: 15802405)
1. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
Johnson SR; Ettinger B; Macer JL; Ensrud KE; Quan J; Grady D
Obstet Gynecol; 2005 Apr; 105(4):779-87. PubMed ID: 15802405
[TBL] [Abstract][Full Text] [Related]
2. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.
Ettinger B; Ensrud KE; Wallace R; Johnson KC; Cummings SR; Yankov V; Vittinghoff E; Grady D
Obstet Gynecol; 2004 Sep; 104(3):443-51. PubMed ID: 15339752
[TBL] [Abstract][Full Text] [Related]
3. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
[TBL] [Abstract][Full Text] [Related]
4. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
5. Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
Steiner AZ; Xiang M; Mack WJ; Shoupe D; Felix JC; Lobo RA; Hodis HN
Obstet Gynecol; 2007 Mar; 109(3):581-7. PubMed ID: 17329508
[TBL] [Abstract][Full Text] [Related]
6. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
Simon JA; Bouchard C; Waldbaum A; Utian W; Zborowski J; Snabes MC
Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
[TBL] [Abstract][Full Text] [Related]
7. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.
Yaffe K; Vittinghoff E; Ensrud KE; Johnson KC; Diem S; Hanes V; Grady D
Arch Neurol; 2006 Jul; 63(7):945-50. PubMed ID: 16831962
[TBL] [Abstract][Full Text] [Related]
8. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of a constant-estrogen, pulsed-progestin regimen in hormone replacement therapy.
Sulak PJ; Caubel P; Lane R
Int J Fertil Womens Med; 1999; 44(6):286-96. PubMed ID: 10617250
[TBL] [Abstract][Full Text] [Related]
10. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
Haines C; Yu SL; Hiemeyer F; Schaefers M
Climacteric; 2009 Oct; 12(5):419-26. PubMed ID: 19479489
[TBL] [Abstract][Full Text] [Related]
11. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
12. The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women.
Huang A; Yaffe K; Vittinghoff E; Kuppermann M; Addis I; Hanes V; Quan J; Grady D
Am J Obstet Gynecol; 2008 Mar; 198(3):265.e1-7. PubMed ID: 18313446
[TBL] [Abstract][Full Text] [Related]
13. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of lower and standard dosages of transdermal estradiol on serum estradiol levels and vaginal maturation index.
Rungruxsirivorn T; Panyakamlerd K; Trerattanachart S; Taechakraichana N
J Med Assoc Thai; 2006 Sep; 89(9):1362-7. PubMed ID: 17100370
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
Archer DF; Thorneycroft IH; Foegh M; Hanes V; Glant MD; Bitterman P; Kempson RL
Menopause; 2005; 12(6):716-27. PubMed ID: 16278615
[TBL] [Abstract][Full Text] [Related]
16. Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns.
Di Carlo C; Tommaselli GA; Gargano V; Savoia F; Bifulco G; Nappi C
Climacteric; 2010 Oct; 13(5):442-6. PubMed ID: 20575654
[TBL] [Abstract][Full Text] [Related]
17. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ
Menopause; 2009; 16(1):132-40. PubMed ID: 18971794
[TBL] [Abstract][Full Text] [Related]
18. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
[TBL] [Abstract][Full Text] [Related]
19. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
Valiati B; Capp E; Edelweiss MI; de Freitas FM; Wender MC
Maturitas; 2009 Jan; 62(1):81-4. PubMed ID: 19097715
[TBL] [Abstract][Full Text] [Related]
20. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
Archer DF; Pickar JH; MacAllister DC; Warren MP
Menopause; 2012 Jun; 19(6):622-9. PubMed ID: 22282101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]